According to a story from med.miami.edu, a team of researchers working at the Sylvester Comprehensive Cancer Center, which is part of the University of Miami School of Medicine, made a significant discovery that could lead to a new approach to treating acute myeloid leukemia. Data from their research revealed than inhibiting an enzyme called CARM1 (also known as PRMT4) was able to slow down the progression of acute myeloid leukemia.

The AAMDSIF 2018 Scientific Symposium Patient Summary is now available in print format.
Containing 30 lay language summaries of presentations from a panel of international experts,

Don’t give up hope, because the chances of finding a cure for acute myeloid leukemia (AML) are improving every day.

Attenuated doses of hypomethylating agents (HMA) early in treatment could improve outcomes among transfusion independent patients with lower-risk myelodysplastic syndromes (MDS), according to findings that will be presented at the American Society of Clinical Oncology 2018 Annual Meeting in Chicago, Illinois.1

Handy list to keep for potential evacuations.  

From FEMA

New research suggests a bedside visual art intervention (BVAI) can reduce pain and anxiety in inpatients with hematologic malignancies, including those undergoing transplant.